Key Events This Week
2 Feb: New 52-week low (Rs.76)
3 Feb: Intraday high and strong gap up (Rs.84.99)
4 Feb: Continued upward momentum (Rs.85.36 close)
5-6 Feb: Minor pullback and consolidation (Rs.84.02 and Rs.84.22)
Mar 23
BSE+NSE Vol: 1.06 lacs

A sharp decline of 4.17% today dragged Themis Medicare Ltd to a fresh 52-week low of Rs 72.39, extending a downward trajectory that has seen the stock lose over half its value in the past year.
Read full news article
Themis Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 Feb 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Themis Medicare Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.73.63 today, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in both its financial performance and market sentiment.
Read full news article
Themis Medicare Ltd has reached a new 52-week low of Rs.73.79 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and market valuation.
Read full news article
Themis Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 Feb 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 09 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and market standing.
Read full news article
Themis Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 February 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Themis Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 February 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 14 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook.
Read full news articleThemis Medicare Ltd's latest financial results for the quarter ended September 2025 reveal significant operational challenges. The company reported net sales of ₹77.99 crores, reflecting a decline of 33.35% year-on-year and a decrease of 20.08% from the previous quarter. This marks the weakest quarterly performance in over two years, indicating potential issues with market share or product offerings. The operating margin turned negative at -3.97%, a stark contrast to the previous year's margin of 14.64%. This shift suggests a severe deterioration in profitability, compounded by an operating loss of ₹3.10 crores, compared to a profit of ₹17.13 crores in the same quarter last year. The net profit for the quarter was reported at a loss of ₹3.62 crores, which is a significant decline from prior periods. Over the first half of FY26, Themis Medicare has accumulated losses totaling ₹17.84 crores, contrasting sha...
Read full news article